Related Experiment Video
Updated: Mar 18, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
687
Depression with Mixed Features in Adolescent Psychiatric Patients
Elisabeth A Frazier1,2, Lance P Swenson3, Tracy Mullare4,5
1Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA. elisabeth_frazier@brown.edu.
Child Psychiatry and Human Development
|June 29, 2016
Summary
Pediatric depression with mixed features (MXD) shows more mania symptoms and higher comorbidity than other depression types. MXD adolescents also report increased suicidality, anger, and trauma, indicating a distinct clinical profile.
Area of Science:
- Child and Adolescent Psychiatry
- Mood Disorders Research
- Pediatric Mental Health
Background:
- Depression with mixed features (MXD) is understudied in pediatric populations.
- Understanding MXD is crucial for accurate diagnosis and treatment in adolescents.
- Existing research lacks detailed comparisons of MXD with other depressive disorders in youth.
Purpose of the Study:
- To compare symptoms and correlates of adolescent inpatients diagnosed with depression with mixed features (MXD).
- To differentiate MXD from Consensus Bipolar (CB) and Depression Only (DO) diagnoses in a pediatric sample.
- To investigate unique clinical characteristics associated with MXD in adolescents.
Main Methods:
- Diagnostic interviews and self-report measures administered to 407 adolescent inpatients.
- Categorization into MXD (n=38), CB (n=79), or DO (n=145) groups based on diagnostic criteria.
- Chart reviews for demographic data, comorbidity, and clinical information.
Main Results:
- Adolescents with MXD exhibited more mania-related symptoms than those with DO.
- MXD group showed elevated Unusually Energetic symptoms and other mania-related symptoms compared to the CB group.
- MXD adolescents reported higher rates of comorbid disorders, suicidality, anger, and trauma symptoms than CB and DO groups.
Conclusions:
- Adolescents with depression with mixed features present with a distinct and elevated symptom profile.
- MXD in pediatric samples may represent a unique diagnostic entity requiring further research.
- Findings highlight the need for specialized assessment and treatment strategies for adolescent MXD.
Related Concept Videos
01:18Depression: Overview
1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
01:27Depressive Disorders: MDD and Dysthymia
1.0K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.0K
01:27Depressive Disorders: Etiology
834
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
834
01:23Antidepressant Drugs: MAOIs and Other Agents
1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
01:30Bipolar Disorder
1.3K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.3K
01:28Psychosis and Antipsychotic Drugs: Overview
1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K